- Telehealth Visits
- Insurance plan information
Melanie C. Majure, MD
Breast Medical Oncology- Telehealth Visits
- Insurance plan information
Melanie C. Majure, MD
Breast Medical Oncology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Medical Oncology, American Board of Internal Med/Medical Oncology
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Hematology - Oncology, University of CA at San Francisco - Pathology GME
Residency
- Internal Medicine, Stanford University Medical Center-GME
Internship
- Internal Medicine, Stanford University Medical Center-GME
Degree
- MD, Stanford University School of Medicine
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 90 reviews
- January 30, 20265 out of 5 Stars
Dr. Majure is an excellent provider. She is professional, compassionate, and explains what she is prescribing. She always answers my questions, and listens to my concerns. Most of all, she cares about her patients.
- January 4, 20265 out of 5 Stars
Dr. Majure is an exceptional physician who combines sharp clinical reasoning with genuine empathy. She grasps my condition, asks insightful questions, and articulates what's going on in a way that's clear and reassuring. Her guidance is thoughtful, evidence-based, and has made a meaningful difference in how I feel and how I manage my condition.
- January 1, 20265 out of 5 Stars
My doctor is outstanding!
- December 8, 20255 out of 5 Stars
I would whole heartly recommend the doctor to family and friends.
- December 3, 20255 out of 5 Stars
Dr. Majure is an excellent and thoughtful clinician. Always informed and attentive with compassion.
- November 20, 20255 out of 5 Stars
Dr. Majure is fantastic!
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.